In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Nastech gets $4mm in private placement

11 Apr 2001

Executive Summary

Nastech Pharmaceutical (nasally delivered drugs) netted approximately $4mm from its private placement of 860k shares of common stock to selected accredited investors including SAFECO Growth Opportunities Fund and an asset management division of a money center bank. Investors were also issued warrants to purchase an additional 420k common shares, exercisable at $6.34 each for five years.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By